• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS HYBRITECH PSA REAGENT; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS HYBRITECH PSA REAGENT; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS Back to Search Results
Catalog Number 37200
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/09/2015
Event Type  malfunction  
Event Description
The customer reported a lower than expected prostate-specific antigen (access hybritech psa) result for one (1) patient on the access 2 immunoassay system (serial number (b)(4)).The physician questioned the initial result as the patient was known to have previously elevated access hybritech psa results.On (b)(6) 2015 the patient's prostate-specific antigen (psa) was tested at a reference laboratory (quest diagnostics) on an alternate methodology (siemens) and a higher result above the normal reference range was obtained.The customer stated the initial access hybritech psa result was reported outside the laboratory.There was no report of patient injury or change in patient treatment associated with this event.The customer noted that quality control (qc), assay calibration, a precision test and system check were performing within specifications at the time of the event.The patient's sample was collected in a serum tube and analyzed from a 2ml sample cup.The sample was centrifuged at 3,250 rpm (revolutions per minute) for ten (10) minutes at room temperature.The customer did not report any issues with sample integrity.
 
Manufacturer Narrative
The customer did not supply demographic for the patient such as the exact date of birth and weight.Service was not dispatched.There is no evidence that the access hybritech psa reagent was returned for evaluation.In conclusion, the cause of the event cannot be determined with the available information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS HYBRITECH PSA REAGENT
Type of Device
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer Contact
jeffrey koll
1000 lake hazeltine drive
chaska, MN 55318
9523681361
MDR Report Key4511994
MDR Text Key5404390
Report Number2122870-2015-00101
Device Sequence Number1
Product Code LTJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K974816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/16/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2015
Device Catalogue Number37200
Device Lot Number430121
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/16/2015
Initial Date FDA Received02/12/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/01/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Age74 YR
-
-